As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...

A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the University ...

Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

Oncology nurses can educate patients on the benefits of subcutaneous administration, including reduced time in the infusion ...

The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...